Connective Tissue Disease
21
6
6
7
Key Insights
Highlights
Success Rate
70% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
14.3%
3 terminated out of 21 trials
70.0%
-16.5% vs benchmark
38%
8 trials in Phase 3/4
71%
5 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (21)
Auto-immunity and Pulmonary Arterial Hypertension
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
Ganglion Resection Effectiveness Trial
A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa
Personalized Outreach for Equitable Treatment in Rheumatology
AYLo - AutoimmunitY and Loss of y
Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases (BAMBOO)
Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease
A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH
Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases
Exercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary Hypertension
A Study of LY2127399 in Participants With Systemic Lupus Erythematosus
A Study of LY2127399 in Participants With Systemic Lupus Erythematosus
On Open-Label Study in Participants With Systemic Lupus Erythematosus
A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
A Clinical Trial for CTD-ILD Treatment
Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus
The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease
Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)
A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease